ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 31 filers reported holding ENVVENO MEDICAL CORPORATION in Q4 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,432,818 | -3.5% | 653,870 | 0.0% | 0.37% | -5.2% |
| Q1 2024 | $3,557,053 | -17.5% | 653,870 | -22.0% | 0.39% | +43.7% |
| Q4 2023 | $4,309,170 | +264.8% | 838,360 | +282.5% | 0.27% | +98.5% |
| Q3 2023 | $1,181,380 | +75.0% | 219,180 | 0.0% | 0.14% | +112.5% |
| Q2 2023 | $675,074 | -34.2% | 219,180 | 0.0% | 0.06% | -66.8% |
| Q1 2023 | $1,025,762 | -8.2% | 219,180 | 0.0% | 0.19% | -13.5% |
| Q4 2022 | $1,117,818 | -18.8% | 219,180 | 0.0% | 0.22% | +26.7% |
| Q3 2022 | $1,376,000 | +66.0% | 219,180 | 0.0% | 0.18% | +24.8% |
| Q2 2022 | $829,000 | -40.6% | 219,180 | 0.0% | 0.14% | -2.8% |
| Q1 2022 | $1,396,000 | -3.3% | 219,180 | 0.0% | 0.14% | -12.7% |
| Q4 2021 | $1,444,000 | – | 219,180 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 653,870 | $3,432,818 | 0.37% |
| ADAR1 Capital Management, LLC | 201,728 | $1,059,072 | 0.20% |
| Nantahala Capital Management | 477,855 | $2,508,739 | 0.15% |
| Perceptive Advisors | 623,315 | $3,272,404 | 0.08% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 230,790 | $1,211,648 | 0.08% |
| Westside Investment Management, Inc. | 38,762 | $203,505 | 0.05% |
| Fermata Advisors, LLC | 30,949 | $162,482 | 0.04% |
| Laird Norton Wetherby Trust Company, LLC | 33,000 | $173,250 | 0.02% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 14,000 | $73,500 | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 139,774 | $733,935 | 0.00% |